These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16595220

  • 1. Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist.
    Giampietro F, Sancilio S, Tiboni GM, Rana RA, Di Pietro R.
    Fertil Steril; 2006 Feb; 85(2):412-9. PubMed ID: 16595220
    [Abstract] [Full Text] [Related]

  • 2. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY.
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [Abstract] [Full Text] [Related]

  • 3. GnRH agonist versus GnRH antagonist in IVF/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis in granulosa cells.
    Lavorato HL, Oliveira JB, Petersen CG, Vagnini L, Mauri AL, Cavagna M, Baruffi RL, Franco JG.
    Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):61-5. PubMed ID: 22884794
    [Abstract] [Full Text] [Related]

  • 4. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

  • 5. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F, Cobellis L, Mele D, Tassou A, Badolati B, Sorrentino S, De Lucia D, Colacurci N.
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [Abstract] [Full Text] [Related]

  • 6. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P.
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [Abstract] [Full Text] [Related]

  • 7. GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells.
    Khalaf M, Mittre H, Levallet J, Hanoux V, Denoual C, Herlicoviez M, Bonnamy PJ, Benhaim A.
    Reprod Biomed Online; 2010 Jul; 21(1):56-65. PubMed ID: 20457540
    [Abstract] [Full Text] [Related]

  • 8. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).
    Garcia-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohí J, Simón C, Pellicer A.
    Hum Reprod; 2001 Dec; 16(12):2533-9. PubMed ID: 11726570
    [Abstract] [Full Text] [Related]

  • 9. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures.
    Ruvolo G, Bosco L, Pane A, Morici G, Cittadini E, Roccheri MC.
    Fertil Steril; 2007 Mar; 87(3):542-6. PubMed ID: 17126339
    [Abstract] [Full Text] [Related]

  • 10. Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.
    Cavagna M, Maldonado LG, de Souza Bonetti TC, de Almeida Ferreira Braga DP, Iaconelli A, Borges E.
    Fertil Steril; 2010 Jun; 94(1):167-72. PubMed ID: 19342035
    [Abstract] [Full Text] [Related]

  • 11. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
    Farhi J, Ben-Haroush A, Lande Y, Sapir O, Pinkas H, Fisch B.
    Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
    [Abstract] [Full Text] [Related]

  • 12. Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist.
    Dong M, Huang L, Wang W, Du M, He Z, Mo Y, Yang D.
    Pharmazie; 2011 Jun; 66(6):436-9. PubMed ID: 21699083
    [Abstract] [Full Text] [Related]

  • 13. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
    Gómez-Palomares JL, Acevedo-Martín B, Chávez M, Manzanares M, Ricciarelli E, Hernández ER.
    Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
    [Abstract] [Full Text] [Related]

  • 14. Morphometric and ultrastructural analysis of human granulosa cells after gonadotrophin-releasing hormone agonist or antagonist.
    Centurione L, Giampietro F, Sancilio S, Piccirilli M, Artese L, Tiboni GM, Di Pietro R.
    Reprod Biomed Online; 2010 May; 20(5):625-33. PubMed ID: 20335069
    [Abstract] [Full Text] [Related]

  • 15. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, Satiroglu H.
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [Abstract] [Full Text] [Related]

  • 16. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial.
    Galindo A, Bodri D, Guillén JJ, Colodrón M, Vernaeve V, Coll O.
    Gynecol Endocrinol; 2009 Jan; 25(1):60-6. PubMed ID: 19165664
    [Abstract] [Full Text] [Related]

  • 17. Granulosa cells apoptosis and follicular fluid hormones: comparison of progestin-primed ovarian stimulation versus GnRH antagonist protocols.
    Li X, Zhang X, Cai J, Pang J, Sun P, Chen J, Wang M, Liang X.
    Gynecol Endocrinol; 2021 Jul; 37(7):609-613. PubMed ID: 33092415
    [Abstract] [Full Text] [Related]

  • 18. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
    Nyachieo A, Spiessens C, Chai DC, Mwenda JM, D'Hooghe TM.
    Fertil Steril; 2009 Feb; 91(2):602-10. PubMed ID: 18328482
    [Abstract] [Full Text] [Related]

  • 19. A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia.
    Zikopoulos K, Kaponis A, Adonakis G, Sotiriadis A, Kalantaridou S, Georgiou I, Paraskevaidis E.
    Fertil Steril; 2005 May; 83(5):1354-62. PubMed ID: 15866569
    [Abstract] [Full Text] [Related]

  • 20. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I, Stein DE, Keltz MD.
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.